Results 161 to 170 of about 5,405 (217)

PPMO-based exon skipping therapy improves respiratory function in the <i>mdx</i> mouse model of Duchenne muscular dystrophy. [PDF]

open access: yesMol Ther Nucleic Acids
Biswas DD   +13 more
europepmc   +1 more source

Ultrasmall Gold Nanoparticles (2 nm) Decorated with a High Density of Photochemically Switchable Ligands. [PDF]

open access: yesChemistry
Wagner LS   +7 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Pancuronium bromide.

Annals of internal medicine, 1978
Pancuronium bromide is a nondepolarizing muscle relaxant approved to induce skeletal muscle relaxation during anesthesia and to facilitate the management of patients undergoing mechanical ventilation. The use of pancuronium bromide during surgery led to the appreciation that it has advantages over drugs previously used for muscle relaxation.
M F, Roizen, T W, Feeley
openaire   +3 more sources

Status asthmaticus and pancuronium bromide

Critical Care Medicine, 1973
The use of neuromuscular blocking agents as an adjunct to accepted drug therapy in medically irreversible status asthmaticus allows time for the drug therapy to become effective. The accessory muscles of respiration are also relaxed and, therefore, a decrease in oxygen demand by the body occurs.
N, Levin, J B, Dillon
openaire   +2 more sources

Pancuronium Bromide Side Effects

JAMA: The Journal of the American Medical Association, 1973
To the Editor.— Dr. Beam (223:1044, 1973) and Drs. Orkin and Pegg (224:630, 1973) recently reported excessive tachycardia after the intravenous administration of pancuronium bromide in two patients who already had accelerated heart rates. Although pancuronium does have a tendency to increase the heart rate, as a rule, only clinically moderate ...
openaire   +4 more sources

Pancuronium Bromide (Continued)

JAMA: The Journal of the American Medical Association, 1973
To the Editor.— In reference to the LETTER TO THE EDITOR by Beam (223:1044, 1973) we want to state that 0.2 mg/kg pancuronium bromide used by this correspondent as an initial dose to facilitate controlled ventilation is never indicated and reveals a complete lack of familiarity with the clinical pharmacology of pancuronium.
  +5 more sources

Home - About - Disclaimer - Privacy